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ABSTRACT
POSTOPERATIVE PAIN AFTER THE USE OF A
DEXAMETHASONE RINSE AS AN
IRRIGANT PRIOR TO
OBTURATION
Kenan Tarabishy, D.DS.
Marquette University, 2013
Purpose:"The purpose of this randomized, double-blind pilot study was to
determine the effect of dexamethasone on post-operative pain when used as an intracanal
rinse prior to obturation.
Materials and Methods:"Nine!adult!volunteers!consented!to!enroll.!They!
presented!to!the!Marquette!University!School!of!Dentistry!Endodontic!Department!
with!a!diagnosis!of!irreversible!pulpitis.!Patients!recorded!their!baseline!pain!levels!
on!the!numering!rating!scale!(NRS).!Patients!were!randomly!assigned!to!either!
experimental!or!control!group.!Patients!in!the!experimental!group!received!4!
mg/mL!dexamethasone!solution!as!a!final!rinse!prior!to!obturation!were!as!patients!
in!the!control!group!received!saline!as!a!final!rinse.!Patients!recorded!their!pain!
levels!at!3,!6,!12,!24,!and!48!hours!postNoperatively.!Means!and!standard!deviations!
were!calculated.!Treatment!effects!were!analyzed!using!repeated!measures!ANOVA.!
Statistical!significance!was!set!at!p<.05.!
Results:"Eight!patients!returned the participation forms. Pain reduction after
endodontic treatment was statistically significant (p=0.039). There was no significant
difference in post-operative pain between the control and experimental groups (p-0.789).
Conclusion: The patient sample size was not large enough to state any
conclusions with confidence. However, endodontic treatment remains an effective means
of reducing post-operative pain.
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INTRODUCTION
Pain of odontogenic origin has long been a source of anxiety and fear amongst the
general population (Sohn & Ismail, 2005). This fear is so great amongst certain
individuals that it actually serves as a barrier to dental treatment (Nixdorf et al, 2010a;
Sohn & Ismail, 2005). Odontogenic pain has also been a common source of frustration
amongst dentists whom have difficulties in completely relieving their patient’s pain
(Nobuhara et al, 1993). The ability to relieve such terrible pain amongst patients has been
inconsistent, with many patients continuing to experience discomfort after dental
treatment is provided (Nixdorf et al, 2010a). No treatment within the dental profession is
as intimately associated with the fear of pain as is root canal therapy. This perception is
so prevalent that stating something is “worse than a root canal” is a common way of
describing terribly painful experiences (Wong & Lytle, 1991). A recent public poll
sought to emphasize the unpopularity of members of congress by comparing their
favorability ratings to root canals (Public Policy Polling, 2013). The ability to predictably
treat pulpal and periapical diseases in a manner that seeks to minimize or even eliminate
post-operative discomfort experienced by patients could help improve the image of
dentistry within the public realm (Seltzer & Naidorf, 2004a).
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LITERATURE REVIEW
Post-operative pain
A substantial amount of research has been published investigating the prevalence
of post-operative discomfort after the initiation, continuation, and completion of
endodontic therapy. The American Association of Endodontics defines flare-ups as “an
acute exacerbation of asymptomatic pulp or peridradicular pathosis after the initiation or
continuation of root canal treatment” (Glossary of Endodontic Terms, 2012). Tsesis et al
(2008) evaluated the frequency of flare-ups secondary to endodontic therapy through
meta-analysis of six studies that included 982 patients. The analysis showed an 8.4%
frequency of flare-ups (2008). Nixdorf et al (2010a) published a meta-analysis and
systematic review to estimate the presence of odontogenic pain after at least six months
following completion of root canal therapy. The analysis included 26 studies and 2,996
teeth qualified for the final analysis. The frequency of persistent odontogenic pain was
estimated to be at 5.3% after six months post-treatment (95% CI: 35-7.2%). The authors
stated that this is likely a more conservative estimate and that the true figure may be
higher, reflecting the widespread occurrence of post-operative pain.
One of the challenges facing clinicians is that many patients present with dentoalveolar pain due to a non-odontogenic source, yet they are treated with conventional
dental treatments, including root canal therapy. Nixdorf et al (2010b) sought to determine
the presence of non-odontogenic pain after at least six months following completion of
root canal therapy. They conducted a meta-analysis of 10 qualifying studies including
1,125 teeth It was determined that possibly up to half of all cases of persistent tooth pain
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(3.4%; 95% CI: 1.4-5.5%) may be caused in part by non-odontogenic pain.This
highlights the importance of proper diagnosis within the dental profession to prevent
unnecessary irreversible dental treatments such as root canal therapy and eventually in
many cases, extractions. Improved diagnosis and referral for treatment of pain of nonodontogenic origin would ultimately help decrease the frequency of reported cases of
post operative discomfort secondary to endodontic therapy. This in turn could contribute
to improved public perceptions regarding discomfort associated with endodontic therapy
(ElMubarak et al, 2010).
The presence of post-operative pain can become especially problematic when it is
caused by neuropathic pain. The International Association for the Study of Pain defines
neuropathic pain as “pain initiated or caused by a primary lesion in or dysfunction of the
nervous system” (Merskey & Bogduk, 1994). This type of pain can develop as a result of
damage to local neural structures during the root canal procedure itself (Nixdorf et al,
2010a). The damage causes somatosensory changes in the nerves, which manifests as a
constant, burning, and deep ache at the site of treatment with the absence of any clinical
signs of pathology. The greatest obstacle that this presents is that this condition is not
responsive to analgesics, surgery, or any other dental procedures. This painful condition
causes great distress to the patients and much confusion amongst their dental providers.
Neuropathic pain has been reported to affect 3% - 12% of patients after endodontic
therapy (Oshima et al, 2009). The frequency of neuropathic pain after endodontic
procedures is higher than that of any other dental procedure (Oshima et al, 2009). Oshima
et al investigated a cohort of sixteen patients and found that neuropathic pain was more
likely in females (13 of 16), with a predilection for the maxilla (14 of 16). It was found

4!
that tricyclic antidepressants were effective in relieving pain in 68.8% of their patients
(11 of 16). However, 25% (4 of 16) of the patients did not report any relief. In order to
minimize the risk of neuropathic pain following endodontic treatment, utilization of best
endodontic treatment practices, including avoiding overinstrumentation and over
extension of obturation materials is critical (Seltzer & Naidorf, 2004a). Improved
practice and techniques may eventually reduce the frequency and development of
neuropathic pain secondary to endodontic treatment. (Oshima et al, 2009).
There are numerous, well-documented studies that identify predictors of postoperative pain. These predictors are significant in educating both practitioners and
patients. ElMubarak et al (2010) investigated a cohort of 234 patients. They found that
patients who undergo root canal therapy with a history of pre-operative pain have a
15.9% incidence of post-operative pain within 24 hours post-treatment, compared to a
7.1% incidence in those with no reported pre-operative pain. It is important to note that
numbers of patients evaluated for post-operative pain are too small to attach great value
pre-operative as a predictive factor. Rather this study demonstrates that endodontic
treatment is an effective means of relieving pain, with patients having an 89% risk of pain
free after treatment. The authors found a statistically significant difference in the
incidence of post-operative pain between vital teeth, 7.8%, and non-vital teeth, 13.7%. In
a meta-analysis published in 2011, Pak & White confirmed that the incidence of postoperative pain was greatest in patients who presented with pre-operative pain. Thus it
appears that in order to affect any meaningful change in the incidence of post-operative
pain within endodontics that the target population for any pain research be patients with
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existing pre-operative pain, because they are at greater risk of developing post-operative
pain (Pak & White, 2011).
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Pulp Physiology and Inflammation
The understanding of pulp physiology and the body’s inflammatory processes
within the context of the human dental pulp is critical to the development of effective
therapeutic approaches to reducing post-operative pain after root canal treatment (Kim
1990). The pulp is very unique in the human body in that the physical environment of the
dental pulp is a low-compliance environment through encasement by dentin (Ingle,
Bakland, & Baumgartner, 2008). The pulp consists of loose connective tissue that
contains nerves, blood vessels, lymph vessels, interstitial fluids, and a wide array of
immune and connective tissue cells. Odontoblasts form the border between the pulp and
dentin. Fibroblasts are located throughout the pulp that function in maintaining the
fibrous extra cellular matrix of the pulp (Ingle, Bakland, & Baumgartner, 2008).
Blood flow to the pulp is provided by very small arterioles, approximately 100
µm in diameter that enters through the apical foramen. Blood from the arterioles are
distributed through an extensive network of branching capillaries, nearly 10 µm in
diameter, which provides an efficient pathway for the distribution of nutrients. This
system is so efficient that every minute the pulp is able to replace the entire blood volume
within the vasculature five to fourteen times. Lymph vessels that are located in the central
part of the pulp is the only mechanism to remove proteins that leak from the blood
vessels, and this becomes of critical importance during reversible pulpitis (Oehmke et al
2003). It is important to note however that there is no source of collateral circulation to
the pulp, a fact that has significant consequences in the presence of inflammation (Ingle,
Bakland, & Baumgartner, 2008).
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There are both autonomic and sensory nerves present in the dental pulp.
Sympathetic autonomic nerves have been found to have a regulatory effect on pulpal
blood flow, with stimulation causing vasoconstriction of the arterioles. There are two
types of sensory nerve fibers: A-fibers and C-fibers. Nearly 90% of pulpal A-fibers are
A-delta fibers, which are myelinated, fast conducting, low threshold nerve fibers that are
unable to survive in hypoxic environments. The remaining 10% of pulpal A-fibers are Abeta fibers that provide propioceptive feedback. C fibers are unmyelinated, slow
conducting, and high threshold nerve fibers that are able to survive in hypoxic
environments. Responses to A-delta fibers are characterized by an immediate and sharp,
sometimes stabbing-like pain, were as responses to C fibers are characterized by a
prolonged dull type of pain (Kim 1990).
External irritants initiate the inflammatory process in the pulp. These irritants can
be mechanical irritants such as the friction and heat that is generated when a bur cuts on
tooth structure. These irritants could also be chemical, which includes bacteria, bacterial
by-products, and even chemical rinses such as concentrated phosphoric acid utilized
during cavity preparation. However, the penetration of bacteria and their by-products are
by far the most common cause of inflammation to the pulp (Siqueira & Barnett, 2004).
The inflammatory process in the pulp is the same as in the rest of the body, and is
mediated by the same cells and pathways, with the only difference being the pulp’s lowcompliance environment (Ingle, Bakland, & Baumgartner, 2008).
Dendritic cells present in the pulp release interleukin-8 (IL-8), which serves as a
powerful chemotactic agent for other inflammatory cells, including neutrophils,
macrophages, and mast cells (Siqueira & Barnett, 2004). Histamine, a potent vasodilator,
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is released from mast cells, resulting in vasoldilation of the arterioles and leakage of the
venules. This leads to a further increase in inflammatory infiltrate in the pulp as well as
their chemical mediators. There are two main consequences as a result of this increase in
infiltrate, both of which are synergistic: Increase in tissue pressure, and increase in
inflammatory infiltrate (Caviedes-Bucheli et al, 2008). The first is that the increased
osmotic pressure, a result of the increased protein concentration released from
inflammatory cells within the pulp, quickly leads to an increase in tissue pressure. The
low-compliance environment of the pulp prevents the dissipation of the increased tissue
pressure. As a result, pulpal blood flow is decreased. In high-compliant tissues, increased
blood flow allows the removal of inflammatory mediators and cells, thus limiting any
excessive damage to the local site. As a result of the pulp’s decreased blood flow, there is
instead a rapid accumulation of inflammatory cells and mediators, which only leads to
greater vascular damage (Heyeraas 1985). This vicious cycle eventually leads to tissue
necrosis.
The second main consequence is the cascade of pro-inflammatory mediators and
their subsequent effects on pulpal tissue throughout the progression of the inflammatory
process. These mediators are released from multiple cells and include in part: histamine,
serotonin, prostaglandins, leukotrienes, platelet activating factor (PAF), substance P (SP),
and a wide host of enzymes that activate several different pro-inflammatory pathways
(Siqueira & Barnett, 2004). Histamine and serotonin are released from mast cells and
platelets respectively, yet both act on local vasculature to cause increased permeability
through the contraction of the blood vessels’ smooth muscle (Seltzer & Naidorf, 2004b).
Prostaglandins and leukotrienes are very important pro-inflammatory chemical mediators
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that orginate from the same precursor, arachidonic acid. Cycloxygenase enzymes convert
arachidonic acid to prostaglandins and thromboxanes and lipoxygenase convert
arachidonic acid to leukotrienes (Seltzer & Naidorf, 2004b). These pathways are
diagrammed in figure 2.

Figure 1 - Arachidonic acid pathway leading to formation of multiple inflammatory mediators
(Yudcovitch).

!
Prostaglandins function to cause vasodilation in local vessels, promote
chemotaxis of inflammatory cells, and sensitize the receptors of pain fibers to stimulation
by other mediators such as bradykinin (Kim 1990). Leukotrienes are from amongst the
most potent chemotactic agents, attracting neutrophils and macrophages that produce
extensive tissue and cellular damage through the release of degradative enzymes such as
lyzozymes (Siqueira & Barnett, 2004). Leukotrienes also have profound effects on
vascular permeability and increase pain through prolonged stimulation of nerve fibers.
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Platelet activating factor is released from various immune cells and acts as a chemotactic
agent, acts on blood vessels to increase vascular permeability, and acting on other cells to
increase the production of other chemical mediators such as serotonin and leukotrienes
(Siqueira & Barnett, 2004). SP is a pro-inflammatory neuropeptide that is released by Cfibers upon stimulation and causes vasodilation, increased vascular permeability, and
pain by lowering the threshold of sensory nerves (Tuncer et al, 2004). Calcitonin gene
related peptide, CGRP, is another neuropeptide released by C-fibers upon stimulation that
acts in a similar fashion as SP (Caviedes-Bucheli et al, 2004). The actions of these
chemical mediators directly and indirectly cause pain at the site of inflammation. This is
done directly through lowering the excitability threshold of the A-delta and C-fibers or
indirectly by way of an increase in edema and tissue pressure. Thus it can be seen that the
accumulation of pro-inflammatory mediators in the dental pulp quickly leads to a cycle of
increased vascular permeability, pain, and ultimately tissue necrosis (Kim 1990). This
cycle is aptly diagrammed in Figure 3.
Many recent studies have demonstrated increased levels of inflammatory
mediators in inflamed pulpal tissues. Bowles et al (2003) measured the concentration of
SP in normal and inflamed pulps through the insertion of micro-dialysis probes into the
pulp. The concentrations of SP were eight times higher in teeth
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Figure 2 - The role of inflammatory mediators in inflammation (Kim 1990).

clinically diagnosed with irreversible pulpitis in comparison to those teeth diagnosed with
normal pulps. Tuncer et al found elevated levels of SP in inflamed periradicular tissues,
highlighting the role that it plays in the spread of inflammation from the pulp to the
periradicular tissues (2004). Lepinski et al (2000) used the same microdialysis probe
technique as Bowles et al to evaluate pulpal concentrations of bradykinin, a potent pain
mediator, in teeth with a clinical diagnosis of irreversible pulpitis as compared to normal
pulps. Bradykinin concentrations were thirteen times greater in teeth with irreversibile
pulpitis as compared to normal pulps. Karapanou et al (2008) obtained gingival
crevicular fluid samples from teeth diagnosed with irreversible pulpitis as well as
adjacent and contralateral teeth with normal pulpal tissues to evaluate the concentration
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of IL-8, an important inflammatory chemotactic agent. It was found that interleukin-8
was significantly elevated in the gingival crevicular fluid of those teeth with irreversibile
pulpitis. Caviedies-Buchelli et al (2004) found significantly higher levels of CGRP in
pulpal tissues collected from teeth with irreversible pulpitis as compared to normal teeth.
A recent article by Yingchun et al (2013) evaluated the expression of EphA7 receptors, a
tyrosine kinase found on the membranes of inflammatory cells, in teeth with normal
pulps and teeth with irreversible pulpitis. Higher expressions of the receptors were found
in inflamed pulps as compared to normal pulps. All of these recent high-level clinical
studies suggest an active role of inflammatory mediators in pulpal inflammation.
Post-operative pain develops when the integrity of the periapical tissues is
compromised. This can occur during endodontic treatment from mechanical irritants such
as hand instruments and obturation materials protruding beyond the minor foramen.
Chemical irritation can occur if any of the solution is extruded beyond the apex. Sealers
used in obturation are often both mechanical and chemical irritants since many
commercially available sealers are cytotoxic (Siqueira & Barnett, 2004). In response to
the tissue irritation, an inflammatory response is initiated, leading to an influx of
inflammatory cells and mediators as described above, ultimately resulting in postoperative pain.
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The Use of Glucocorticosteroids in Dentistry
Disruption of the inflammatory cycle has long been the focus of pain research.
The primary target sites for pharmacological approaches have been two classes of
enzymes: phospholipase, which synthesizes arachidonic acid from phospholipids, and
cyclooxygenase, which synthesizes prostaglandins. Steroidal anti-inflammatory drugs
(SAID), also known as glucosteroids, are a class of drugs that function by inhibiting
phospholipase A2, thus reducing the production and concentrations of prostaglandins and
leukotrienes (Seltzer & Naidorf, 2004b). Non-steroidal anti-inflammatory drugs
(NSAIDS), are a class of drugs that function by inhibiting cyclooxygenase enzymes,
which reduces prostaglandins but does not affect leukotriene production (Seltzer &
Naidorf, 2004b).

Figure 3 - Pharmacologic targets in the arachidonic acid pathway (Yudcovitch).

!
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Histology has been used frequently to evaluate the direct anti-inflammatory
effects of corticosteroids on periapical inflammation and pathology. Metzger et al (2002)
studied the effect of dexamethasone on the size of periapical lesions in rats. Bone
resorption is modulated by inflammatory cytokines, thus they hypothesized that
pharmacological modulation of bone resorption is possible. Periapical lesions were
induced in molars of rats in two groups, a control group and an experimental group
administered intramuscular injections of dexamethasone. None of the rats in the
experimental group developed any abscess or overt sign of infection. Histologic
evaluation of the periapical lesions of both groups showed that lesions in the
dexamethasone group were significantly smaller than those of the control group. This
suggested that the systemic administration of dexamethasone inhibited at least partially,
the development of inflammatory periapical lesions. It is possible that dexamethasone
had an inhibitory effect on osteoclasts. The authors found that in the experimental
dexamethasone group, osteoclasts were more likely to undergo apoptosis, ultimately
reducing the number of osteoclasts and limiting the potential for greater resorption.
Nobuhara et al (1993) also used rats to observe any histologic changes due to the
application of dexamethasone in inflamed periapical tissues of molars. The distal roots of
vital and non-vital first molars were over-instrumented with hand files, followed with the
deposition of either saline or dexamethasone via buccal infiltration. The amounts of
neutrophils for each specimen were counted at three time points: 6, 24, and 48 hours, and
at three different locations within the periodontal ligament: adjacent to the apical
foramen, the middle of the ligament, and adjacent to the cancellous bone. For both vital
and non-vital cases, the dexamethasone groups demonstrated significantly less neutrophil
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infiltrate at 48 hours at the apical portion of the periodontal ligament as well as the
middle of the ligament space. Neutrophils are the hallmark cells of acute inflammation,
and any potential method to locally decrease neutrophil concentrations may have
profound impacts on clinical symptoms following endodontic treatment.
One of the effects of periapical inflammation is the presence of neural sprouting
into the periodontal ligament, leading to increased sensitivity upon stimulation of the
periodontal ligament. Holland (1996) sought to determine if systemic dexamethasone
affects neural sprouting. Twenty ferrets had root canal treatment completed on
mandibular canines, with the experimental group administered oral dexamethasone at the
time of treatment. After three months, the ferrets were killed and specimens were
prepared for histological evaluation. It was found that innervation density in the apical
region, as well as the total innervation density of the periodontal ligament, were
significantly lower in the dexamethasone group as compared to the control group.
Isett et al (2003) conducted a double-blind, randomized clinical study to
investigate the effect of methylprednisolone (depo-medrol) on pulpal concentrations of
PGE2 and IL-8. Forty patients with diagnoses of irreversible pulpitis participated. After
being anesthetized, patients were given either intraosseous methylprednisolone or saline.
The teeth were extracted anywhere from 24 hours to 72 hours after the intraosseous
injection. The pulp tissues were extracted from the teeth and the concentrations of the
PGE2 and IL-8 determined via enzyme immunoassay. The pulpal concentrations of PGE2
were significantly reduced at 24 hours post injection, but not at seventy-two hours.
Much clinical research also has been produced on the use of SAIDS and their
effect on inflammation and postoperative pain (Shariar et al, 2013; Marshall & Walton,
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1984; Liesinger et al, 1993; Jalalzadeh et al, 2010; Chu et al, 2006; Ehrmann et al, 2003;
Negm et al, 2001). Various modes of administration have been used, ranging from
intramuscular injections to intra canal medications (Shariar et al, 2013; Marshall &
Walton, 1984; Liesinger et al, 1993; Jalalzadeh et al, 2010; Chu et al, 2006; Ehrmann et
al, 2003; Negm et al, 2001). A recent study by Jalalzadeh et al (2010) administered a
prednisolone pill 30 minutes before treatment to both vital and non-vital teeth in patients
completed in one visit. 40 patients participated in this double blind study with patients
divided equally between the placebo group and the prednisolone group. Prednisolone
resulted in a statistically significant reduction in post-endodontic pain at 6, 12, and 24
hours following treatment. Marshall and Leisenger (1993) carried out a double blind
study evaluating the effect of 4 mg dexamethasone i.m. on post-operative pain in patients
with both vital and non-vital teeth. Fifty patients were included in the placebo controlled
experiment. Pain levels were recorded at 4 hours, 24 hours, and 48 hours postoperatively. Patients in the experimental group had significantly lower pain levels at 4
hours post-operatively compared to the placebo group. Rogers et al (1999) investigated
the analgesic effects of a dexamethasone rinse in symptomatic vital cases in treatments
completed in two visits. Forty-eight patients participated and were divided into four
groups: placebo pills to be taken post-operatively, oral ibuprofen to be taken postoperatively, dexamethasone (4 mg/ml) intra canal rinse, and ketorolac intra canal rinse.
The patients recorded their pain levels at 6, 12, 24, and 48 hours post-operatively.
Dexamethasone provided statistically significant pain relief at 12 hours as compared to
placebo, but the difference between dexamethasone and ketrolac and ibuprofen was not
significant statistically.
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Ehrmann et al (2003) sought to evaluate whether Ledermix, a corticosteroid and
antibiotic paste, reduced the incidence of post-operative pain in necrotic teeth. Two
hundred and twenty one patients were randomized to treatments: ledermix, calcium
hydroxide (CaOH), and no medication. Patients in the Ledermix group had consistently
less post-operative pain at all observed time points as compared to patients in the CaOH
and placebo groups (2003).
In 2001, Negm et al (2001) published a double blind, randomized study
evaluating the efficacy of dexamethasone as an intra-canal medicament in the treatment
of inter-appointment pain in patients undergoing root canal therapy on vital teeth. Postoperative pain levels were evaluated up to 48 hours. 480 Patients who needed endodontic
therapy received either the corticosteroid-antibiotic medicament, or a placebo. Over 93%
of the patients assigned to the steroid group had complete relief of pain within the first 24
hours, compared to only 22% in the placebo group. The most significant factor in this
study was the large size of participants in each group, with over 248 patients in the
experimental group and 232 patients in the control group. A weakness in the Negm study
is that the SAID and antibiotic were mixed into one medicament, making it difficult to
draw conclusions about the efficacy of either component alone. It would have been more
appropriate to have two experimental groups: a SAID group, and an antibiotic group.
The purpose of this prospective, randomized, double blind clinical trial was to
determine the effect of dexamethasone on post-operative pain in patients with irreversible
pulpitis when used as an intracanal rinse prior to obturation in treatment completed in one
visit.
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MATERIALS & METHODS
The research design was based on a study previously executed by Mahajan
(2012). Second year endodontic residents screened potential participants at the
Endodontic Clinic at Marquette University School of Dentistry in Milwaukee, Wisconsin.
The candidate’s medical history was evaluated through their written health history in
addition to oral examination. A candidate was enrolled if they met the following criteria:
Inclusion Criteria:
•

Older than 18 years of age;

•

Being a patient of record;

•

Vital tooth with pulpal diagnosis of symptomatic irreversible pulpitis;

•

A pre-operative pain score of at least a four on the numeric rating scale,
henceforth known as NRS;

•

Treatment completion in one visit;

•

Potential to achieve canal patency as determined on pre-operative
radiographs

•

The candidate’s ability to understand and provide informed consent.

Exclusion Criteria:
•

Did not sign the consent form

•

History of significant medical history, classified as class II or higher by
the American Society of Anesthesiologists classification;

•

Nursing or pregnant patients;

•

Past history of peptic ulcer or gastrointestinal bleeding;

•

High risk for renal failure or impairment;
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•

Presence of allergy or hypersensitivity to non-steroidal anti-inflammatory
drugs or corticosteroids;

•

Radiographic evidence of periapical pathology;

•

Recent intake of anti-inflammatory drugs, antibiotics, or narcotics;

•

Presence of adjacent, symptomatic teeth.

The Marquette University Institutional Review Board approved the study
(Protocol HR-2195, see Appendix), and written informed consent was obtained from
each patient prior to enrollment in the study. Participants were compensated for their time
and effort through mail delivery of a $25 VISA® gift card. Pulpal and periapical tests
were conducted to determine the pulpal and periapical diagnoses. A preoperative
radiograph was taken to rule out periapical pathology. In addition, a comprehensive
clinical examination was completed to rule out intra/extraoral swelling, presence of a
sinus tract, or other major pathology.
Prior to anesthetizing the treatment area, patients were asked to rate their pain on
a numeric pain intensity scale otherwise know as a numeric rating scale (NRS) (Figure
1). The scale was from 0, being no pain, to 10, being the worst possible, unbearable,
excruciating pain. The NRS score was considered the baseline pain level of the patient.
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Figure 4 - The numeric rating scale was by patients to determine their pain levels.

Eligible patients were randomly assigned by a research assistant, without
knowledge of the clinical investigator, to one of two groups:
•

Group 1 was the experimental group that received the dexamethasone rinse in
addition to standard of care therapy;

•

Group 2 was the control group that received the saline rinse in addition to
standard of care therapy.
Randomization tables were generated with the aid of the (pseudo) random number

generator in Microsoft® Excel® for Mac 2011 (Microsoft Corp., Redmond (WA)). A
formula was set to randomly select an integer between 1 and 30 without replacement.
At the initiation of treatment, patients were anesthetized using 1.7- 5.1 mL of 2%
lidocaine with 1:100,000 epinephrine (Xylocaine; AstraZeneca LP, DENTSPLY, York
(PA)) via local infiltration or inferior alveolar nerve block, depending on tooth location.
Prior to beginning treatment, anesthesia was confirmed by retesting the tooth with EndoIce® (Coltene Whaledent Group, Cuyahoga Falls (OH)). After confirmation of complete
anesthesia, a rubber dam was placed, the occlusion was adjusted and the tooth was
accessed. The working length of the root canal instruments was determined and the

21!
canal(s) were prepared with hand and rotary instruments. Each canal was prepared to at
least a size #20 hand file, along with 5.25% sodium hypochlorite (NaOCl) irrigation. A
modified crown-down technique was employed to enlarge the canal in the coronal,
middle and apical thirds using RaCe (Brasseler USA, Savannah (GA)) and
EndoSequence (Brasseler USA, Savannah (GA)) rotary files.
The modified crown-down technique is a technique in which the coronal third of
the canal is instrumented first with large tapered rotary files. Afterwards, the apical third
is instrumented with rotary files, beginning with smaller sized files and increasing in size
until the master file is reached. Throughout the process, the middle third of the canal is
instrumented as well.
After the chemo-mechanical cleaning was completed, a final irrigation with
5.25% NaOCl, 17% ethylenediaminetetraacetic acid (EDTA), and 2% chlorhexidine
(CHX) was performed. This was followed by ultrasonic agitation using a size #15
ultrasonic K-file (Satelec, Merignac, France). Then, the canal was dried with sterile paper
points. At this point, the research assistant gave the practitioner an unlabled 1 mL
tuberculin syringe containing a clear solution that was used to rinse the canals. In Group
1, the solution was 1mL of 4 mg/mL dexamethasone sodium phosphate aqueous solution
(Luitpold Pharmaceuticals, Shirley (NY)), and in Group 2 the solution was 1mL of 9
mg/mL sodium chloride in H2O (Luitpold Pharmaceuticals, Shirley (NY)). Patency of the
canals was rechecked at this point with a hand file of size #10 or greater. The solution
was then agitated with a size #15 ultrasonic K-file for 30 seconds. The canals were dried
again with sterile paper points.
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Obturation was completed by vertical condensation with Brasseler EndoSequence
.04 ISO sized gutta-percha or .06 ISO sized gutta-percha (Brasseler USA, Savannah
(GA)) and AH Plus sealer (DeTrey, Dentsply, Ballaigues, Switzerland). A sterile cotton
pellet was placed in the pulp chamber and the access opening was sealed with Cavit
temporary filling material (Cavit G; 3M ESPE, Seefeld, Germany).
After completion of the endodontic treatment, patients were given post-operative
forms that included rescue medication instructions, explanation of possible adverse
events, and pain level score collection instructions. As rescue medication, all patients
received 4 tablets of 600mg ibuprofen each, to be taken only if pain levels reached or
exceeded 6 on the NRS. In addition, if pain was not manageable, patients were informed
to contact the principal investigator by phone. Patients were instructed to report also any
swelling, fever, or persistent infection. For data collection, patients were requested to
record NRS values at exactly 3, 6, 12, 24, and 48 hrs post-operatively. They were also
instructed to record the amount of rescue medication and when it was taken. Patients
were given stamped, self-addressed envelopes to place the form once completed. Patients
were contacted approximately forty-eight hours post operatively by the principal
investigator to remind the patients to mail the data collection forms. Upon receipt of the
envelope, the research assistant recorded the data, and the principal investigator mailed
the gift card as compensation to the patient’s address. The research data was unblinded to
the principal investigator at the end of the experiment.

!
!
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Statistical Methods
The sample size of necessary root canal treatments was estimated based on the

following: the study design (two parallel groups, 5 measurement points for each patient),
a desirable and clinically relevant effect size, type I error rate of 5%, and type II error rate
of 10%. Figure 4 shows the sample size estimates as a function of various study design (2
parallel treatment groups, 5 data collection time points) and statistical parameters (type I
error, type II error, effect size). Given these premises, the goal was to enroll 30 patients.

!
Figure 5 - Sample size as a function of size and power.

Statistical analyses included computation of means, s.d. and 95% confidence
intervals. In addition, a repeated measure analysis of variance was executed to investigate
statistical within- and between-subjects trends and to generate information that could be
used for the planning of larger clinical studies. The patient was used as a unit for all
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statistical calculations. The sample included 8 patients (Ntest = 5, Ncontrol = 3). Treatment
(Test, Control) was the independent variable. Time (baseline, 3 hrs, 6 hrs, 12 hrs, 24 hrs,
and 48 hrs) was the repeated factor. NRS was the dependent variable. Microsoft®
Excel® 2010 (Microsoft Corp., Redmond, WA) and SPSS (Version 20, IBM
Corporation, Chicago, IL) were used for data analyses.
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RESULTS
Nine patients, three males and six females with an average of 36 years of age
consented to participate in the study. Eight patients completed the pain evaluation forms
and returned the forms by mail; the ninth patient did not submit her pain evaluation form.
Of the remaining eight patients, the teeth that were treated included four molars, three
anteriors, and one premolar. Three patients were assigned to the control group and five to
the experimental group. Patients in the control group reported an average preoperative
pain score of 6.7 ± 2.1 (mean ± 1 s.d.). Patients in the experimental group reported an
average preoperative pain score of 7 ± 1 (mean ± 1 s.d.). The difference in the baseline
preoperative pain levels between both groups was not statistically significant (p=0.767).
The table below shows the pain levels of patients of both groups at all observed time
points.

Patient

Baseline

3hrs

Patient 1
Patient 2
Patient 3

9
5
6

4
6
0

Patient 4
Patient 5
Patient 6
Patient 7
Patient 8

8
6
7
8
6

4
8
7
0
0

6hrs

Control Group
5
7
6
6
1
0
Experimental Group
4
2
4
2
9
10
0
0
0
3

Table 1 – Pain levels for patients over a 48-hour period."

!
!
!

12hrs

24hrs

48hrs

Rescue
medication
taken

6
5
0

5
5
0

0
3
0

0
1
9
0
0

0
1
10
0
0

2
2
3
0
2
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The pain reduction after root canal treatment was statistically significant
(p=0.039). Patients in the experimental group reported greater average post-operative
discomfort at three hours and less post operative discomfort at all other time points in
comparison to the control group. These differences are not statistically significant
(p=0.789).
In the experimental group, two patients experienced moderate to severe
discomfort at three hours. Of the two patients, one reported moderate pain at six hours,
and mild to negligible pain at all other time points. The other patient continued to
experience significant pain, after which she contacted the principal investigator two days
post treatment complaining of swelling. The patient was seen in the endodontic clinic the
following day with mild, intraoral swelling localized around the apex of the treated tooth.
The endodontic resident on emergency rotation that day prescribed the patient a sevenday course of 150mg clindamycin. The patient experienced mild palpation sensitivity for
six more weeks until symptoms completely resolved. Three of the five patients
experienced no post-operative discomfort at 24 hours and 48 hours. This was the only
patient to report swelling. No other adverse effects were noted.
In the control group, two of the three patients reported moderate post-operative
discomfort at all time points. Only one patient in the control group reported resolution of
her symptoms by the end of the observed period.
Six out of the eight patients reported taking the provided 600mg ibuprofen tablets
as rescue medication: Four out of the five patients in the experimental group and one out
of three patients in the control group.

!
!

Figure 6 - Reported pain levels for individual patients.
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DISCUSSION!
!
The present study was planned to be a continuation of Mahajan’s thesis work

(2012) on the use of a dexamethasone rinse as an irrigant prior to obturation. Mahajan
(2012) found a statistically significant improvement in the post-operative pain
experienced by patients in the experimental group. Ten patients participated in Mahajan’s
study. The purpose of the current study was to enact a few procedural modifications
while expanding the patient base.
The greatest limitation in the present study was the low number of participants.
After encouraging results from Mahajan’s (2012) pilot study, one of the primary aims of
this study was to increase the sample size. However, the study concluded with two less
participants than the initial study. One possible restrictive requirement may have been the
requirement that the treatment be completed within one visit. Oftentimes patients who
presented to the emergency clinic were not able to participate because their insurance
providers necessitated approval prior to completion of the root canal. Unfortunately there
is no data available on how many patients were screened and for what reasons they were
excluded from the study. That data would have been beneficial in designing future
clinical trials.
The results of this study indicated that standard of care root canal treatment is an
effective means to relieve odontogenic pain. The sample size was too small to make any
conclusion in regards to the efficacy of dexamethasone on post-operative pain. After the
three-hour mark, the average pain levels of the dexamethasone group were lower than the
control.
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Several modifications were made to the original protocol developed by Mahajan
(2012) to improve the clinical relevance of the study. The study was changed from a
single blind to a double-blind study through the addition of a placebo rinse. Also, data
were no longer reported directly to the primary investigator. In an effort to reduce any
potential bias, patients recorded their pain scores and returned the form via mail, after
which a research assistant recorded the data. Finally, the pain observation period was
extended from 24 hours to 48 hours to determine the effects of dexamethasone over a
longer period of time.
Previous studies documented the usage of a steroid medication on either interappointment or post-operative discomfort related to endodontic treatments. However,
most of these studies evaluated post-operative discomfort during multiple appointments.
Chance et al (1987) and Rogers et al (1999) both evaluated post-operative pain after
initial treatment. The large clinical trial published by Negm et al (2003) saw treatment
completed in three visits, with dexamethasone used as an inter-appointment medicament
rather than a final rinse. Liesinger et al (1993) evaluated post-operative discomfort in
single visit treatment of vital teeth, however the mechanism of delivery for
dexamethasone was through intramuscular injection.
This study focused on single visit treatments due to increasing prevalence
amongst endodontists of treatment completed in one visit, particularly when treating
cases with irreversible pulpitis. In a survey by Inamoto et al (2002) completed by 156
endodontists, 55.8% completed emergency visits in one appointment. Due to risks of
flare-ups, a lesser percentage of endodontists completed necrotic emergency visits in one
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apoointment (34.4%). Since the endodontists answered only in response to emergency
cases, the real number of single appointment treatment is likely much higher.
Single visit treatments have become more common due to advancements in dental
materials, namely the development of nickel titanium files rotary files. Unlike traditional
hand instrumentation, rotary instrumentation removes significant amount of debris away
from the apex towards the access cavity, reducing the amount of debris that is extruded
from the apical foramen into the periapical tissues (Cheung et al, 2009). Nickel-titanium
rotary files as well as improved understanding of irrigation have made single appointment
treatment much more accessible (Su et al, 2011). Other advantages include greater patient
acceptance and cost effectiveness (Su et al, 2011).
Su et al (2011) conducted a systematic review of controlled clinical trials
comparing outcome of endodontically treated teeth completed in single visits and
multiple visits. They concluded that the healing rate was similar between the two groups
and that post-operative pain was significantly lower in the single visit treatment group.
Kvist et al (2004) carried out a randomized, clinical trial evaluating the antimicrobial
efficacy of endodontic treatment completed in one visit as compared to two-visit
treatment in teeth with apical periodontitis. Microbial samples were retrieved from 29%
of the one visit group and 36% of the two-visit group, with no significant statistical
difference in the antimicrobial efficacy between the two groups. The Su and Kvist studies
demonstrate the clinical and anti microbial efficacy of endodontic treatment completed in
one visit.
Only teeth with a pulpal diagnosis of irreversible pulpitis were enrolled in the
present study. Chance et al (1987) investigated the use of an intra-canal corticosteroid in
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both vital and necrotic teeth and its effects on post-operative pain after initial treatment in
a randomized, double-blind clinical trial. The frequency of post-operative pain amongst
vital teeth was greater in the control group as compared to the experimental group. This
difference was statistically significant, p=0.007 (1987). There was no significant
difference in post-operative pain in non-vital teeth between the control and experimental
groups.
Researchers have utilized many different modes of delivery for corticosteroids.
Dexamethasone has been administered through local infiltration, extra oral intra-muscular
injections, intra oral intra-muscular injections, oral dosage, and intra canal rinses (Shariar
et al, 2013; Marshall & Walton, 1984; Liesinger et al, 1993; Jalalzadeh et al, 2010; Chu
et al 2006; Ehrmann et al, 2003; Negm et al, 2001). To limit any possible complications
or side effects that may arise from dexamethasone usage, this study used dexamethasone
as an intra canal rinse. Dexamethasone has a plasma half-life of 200 minutes and tissue
half-life of seventy-five hours (Wayman et al, 1994). Systemic absorption of
dexamethasone may produce unwanted actions at other sites of the body such as a
decrease in the body’s healing response (Wayman et al, 1994). Wayman et al (1994),
found that local infiltration of radioactive dexamethasone in the mandibular buccal
vestibule of rats was rapidly absorbed in the systematic circulation and deposited
throughout the tissues. Within one hour of injection, radioactive dexamethasone was
found in the contra-lateral mandible. Although it is difficult to extrapolate conclusions
from animal studies, the use of an intra-canal dexamethasone rinse may be an effective
means of limiting systematic absorption of the drug.
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This study sought to evaluate post-operative pain up to forty-eight hours posttreatment. Liesinger et al (1993) showed that the greatest level of post-operative pain
occurred within the first twenty-four hours following treatment. Their study also showed
that the greatest therapeutic effects of dexamethasone were observed during this time
period. By implementing a 48 hour post-treatment observation period it became possible
to fully document the post-operative pain cycle.
One patient in the experimental group did develop localized swelling after
treatment was completed. No antibiotics were prescribed for patients who enrolled in the
study unless they developed post-operative complications such as swelling, fever, or
lymphadenopathy. A Cochrane systematic review by Keenan et al (2006) concluded that
there was no evidence that antibiotics provided any analgesic effect in patients with
irreversible pulpitis. Rogers et al (1999) suggested that infections secondary to
corticosteroid usage may be possible when the inflammatory response is suppressed.
However, numerous large studies have previously used corticosteroids without any
evidence of fever, swelling, or malaise (Rogers et al, 1999; Negm et al, 2001; Liesinger
et al, 1993; Marshall & Walton, 1994; Jalalzadeh et al, 2010).

!
!
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CONCLUSION
The sample size of this randomized, double blind clinical pilot study does not

allow any conclusion to be made with confidence on the analgesic efficacy of
dexamethasone as a final rinse prior to obturation. Standard of care root canal therapy for
both groups had a statistically significant reduction in post-operative pain, demonstrating
the effectiveness of root canal therapy. A much larger sample size is needed to determine
if there any possible effects dexamethasone may have on post-operative pain.

!
!

34!
BIBLIOGRAPHY

Aggarwal V, Singla M, Rizvi A, Miglani S. Comparative Evaluation of Local Infiltration
of Articaine, Articaine plus Ketorolac, and Dexamethasone on Anesthetic Efficacy
of Inferior Alveolar Nerve Block with Lidocaine in Patients with Irreversible
Pulpitis. Journal of Endodontics 2011; 37(4): 445-49.
Alvarado L, Perry G, Hargreaves K, Henry M. TRPM8 Axonal Expression Is Decreased
in Painful Human Teeth with Irreversible Pulpitis and Cold Hyperalgesia." Journal
of Endodontics 2007; 33(10): 1167-171.
Attar S, Bowles W, Baisden M, Hodges J, Mcclanahan J. Evaluation of Pretreatment
Analgesia and Endodontic Treatment for Postoperative Endodontic Pain. Journal of
Endodontics 2008; 34(6): 652-55.
Bowles W, Withrow J, Lepinski A, Hargreaves K. Tissue Levels of Immunoreactive
Substance P Are Increased in Patients with Irreversible Pulpitis. Journal of
Endodontics 2003; 29(4): 265-67.
Caviedesbucheli J, Munoz H, Azueroholguin M, Ulate E. Neuropeptides in Dental Pulp:
The Silent Protagonists. Journal of Endodontics 2008; 34(7): 773-88.
Caviedesbucheli J, Camargobeltran C, Gomezlarotta A, Cristinatrujillomoreno S,
Morenoabello G, Gonzalezescobar J. Expression of Calcitonin Gene-Related
Peptide (CGRP) in Irreversible Acute Pulpitis. Journal of Endodontics 2004; 30(4):
201-04.
Chance K, Lin L, Shovlin F, Skribner J. Clinical Trial of Intracanal Corticosteroid in
Root Canal Therapy. Journal of Endodontics 1987; 13(9): 466-68.
Cheung G, Liu C. A Retrospective Study of Endodontic Treatment Outcome between
Nickel-Titanium Rotary and Stainless Steel Hand Filing Techniques. Journal of
Endodontics 2009; 35(7): 938-43.
Chu F, Leung W, Tsang P, Chow T, Samaranayake L. Identification of Cultivable
Microorganisms from Root Canals with Apical Periodontitis Following Two-Visit
Endodontic Treatment with Antibiotics/Steroid or Calcium Hydroxide Dressings.
Journal of Endodontics 2006; 32(1): 17-23.
Ehrmann E, Messer H, Adams G. The Relationship of Intracanal Medicaments to
Postoperative Pain in Endodontics. International Endodontic Journal 2003; 36(12):
868-75.
ElMubarak A, Abu-bakr N, Ibrahim Y. Postoperative Pain in Multiple-visit and Singlevisit Root Canal Treatment. Journal of Endodontics 2010; 36(1): 36-39.

35!

Glossary of Endodontic Terms. 8th ed. N.p.: American Association of Endodontists,
2012. Glossary of Endodontic Terms. American Association of Endodontists. Web.
<http://www.nxtbook.com/nxtbooks/aae/endodonticglossary/index.php>.
Holland G. Steroids Reduce the Periapical Inflammatory and Neural Changes after
Pulpectomy. Journal of Endodontics 1996; 22(9): 455-58.
Heyeraas K. Pulpal Microvascular and Tissue Pressure. Journal of Dental Research
1985; 64: 585
Inamoto K., Kojima K, Nagamatsu K, Hamaguchi A, Nakata K, Nakamura H. A Survey
of the Incidence of Single-Visit Endodontics. Journal of Endodontics 2002; 28(5):
371-74.
Ingle J, Bakland L, Baumgartner J. Ingle's Endodontics. Hamilton, Ont.: BC Decker,
2008. Print.
Isett J, Reader A, Gallatin E, Beck M, Padgett D. Effect of an Intraosseous Injection of
Depo-Medrol on Pulpal Concentrations of PGE2 and IL-8 in Untreated Irreversible
Pulpitis. Journal of Endodontics 2003; 29(4): 268-71.
Jalalzadeh S, Mamavi A, Shahriari S, Santos F, Pochapski M. Effect of Pretreatment
Prednisolone on Postendodontic Pain: A Double-blind Parallel-randomized Clinical
Trial. Journal of Endodontics 2010; 36(6): 978-81.
Karapanou V, Kempuraj D, Theoharides T. Interleukin-8 Is Increased in Gingival
Crevicular Fluid from Patients with Acute Pulpitis. Journal of Endodontics 2008;
34(2): 148-51.
Keenan J, Farman A, Fedorowicz Z, Newton J. A Cochrane Systematic Review Finds No
Evidence to Support the Use of Antibiotics for Pain Relief in Irreversible Pulpitis.
Journal of Endodontics 2006; 32(2): 87-92.
Kim, S. Neurovascular Interactions in the Dental Pulp in Health and Inflammation.
Journal of Endodontics 1990; 16.(2): 48-53.
Kvist T, Molander A, Dahlen G, Reit C. Microbiological Evaluation of One- and TwoVisit Endodontic Treatment of Teeth with Apical Periodontitis: A Randomized,
Clinical Trial. Journal of Endodontics 2004; 30(8): 572-76.
Lepinski A, Hargreaves K, Goodis H, Bowles W. Bradykinin Levels in Dental Pulp by
Microdialysis. Journal of Endodontics 2000; 26(12): 744-47.
Liesinger A, Marshall F, Marshall J. Effect of Variable Doses of Dexamethasone on
Posttreatment Endodontic Pain. Journal of Endodontics 1993; 19(1): 35-39.

36!

Mahajan S. Postoperative Pain after the Use of a Dexamethasone Rinse as an Irrigant
Prior to Obturation. Thesis, Marquette University, Milwaukee. 2012.
Marshall J, Liesinger A. Factors Associated with Endodontic Posttreatment Pain. Journal
of Endodontics 1993l; 19(11): 573-75.
Marshall J, Walton R. The Effect of Intramuscular Injection of Steroid on Posttreatment
Endodontic Pain. Journal of Endodontics 1984; 10(12): 584-88.
Merskey H, Bogduk N. "Part III: Pain Terms, A Current List with Definitions and Notes
on Usage. Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes
and Definitions of Pain Terms. 2nd ed. Seattle: IASP, 1994. 209-14.
Metzger Z, Klein H, Klein A, Tagger M. Periapical Lesion Development in Rats
Inhibited by Dexamethasone. Journal of Endodontics 2002; 28(9): 643-45.
Miles,T. Dental Pain: Self-observations by a Neurophysiologist. Journal of Endodontics
1993; 19(12): 613-15.
Negm M. Intracanal Use of a Corticosteroid-antibiotic Compound for the Management of
Posttreatment Endodontic Pain. Oral Surgery, Oral Medicine, Oral Pathology, Oral
Radiology & Endodontics 2001; 92(4) 435-39.
Nixdorf D, Moana-Filho E, Law A, McGuire L, Hodges J, John M. Frequency of
Persistent Tooth Pain after Root Canal Therapy: A Systematic Review and MetaAnalysis. Journal of Endodontics 2010a; 36(2): 224-30.
Nixdorf D, Moana-Filho E, Law A, McGuire L, Hodges J, John M. Frequency of
Nonodontogenic Pain after Endodontic Therapy: A Systematic Review and MetaAnalysis. Journal of Endodontics 2010b; 36(9): 1494-498.
Nobuhara WK, Carnes DL, Gilles JA. Anti-Inflammatory Effects of Dexamethasone on
Periapical Tissues following Endodontic Overinstrumentation. Journal of
Endodontics 1993; 19(10): 501-07.
Oehmke M, Knolle E, Oehmke HJ. Lymph Drainage in the Human Dental Pulp.
Microscopy Research and Technique 2003; 62(3): 187-91.
Oshima K, Ishii T, Ogura Y, Aoyama Y, Katsuumi I. Clinical Investigation of Patients
Who Develop Neuropathic Tooth Pain After Endodontic Procedures. Journal of
Endodontics 2009; 35(7): 958-61.
Pak JG, White SN. Pain Prevalence and Severity Before, During, and after Root Canal
Treatment: A Systematic Review. Journal of Endodontics 2011; 37(4): 429-38.

37!
Public Policy Polling. Poll Results. Congress Less Popular than Cockroaches, Traffic
Jams. N.p., 8 Jan. 2013. Web. 15 Jan. 2013.
<http://www.publicpolicypolling.com/main/2013/01/congress-less-popular-thancockroaches-traffic-jams.html>.
Rogers M, Johnson B, Remeikis N, Begole R. Comparison of Effect of Intracanal Use of
Ketorolac Tromethamine and Dexamethasone with Oral Ibuprofen on Post
Treatment Endodontic Pain. Journal of Endodontics 1999; 25(5): 381-84.
Seltzer S, Naidorf I. Flare-ups in Endodontics: I. Etiological Factors. Journal of
Endodontics 2004a; 11(11): 472-78.
Seltzer S, Naidorf I. Flare-ups in Endodontics: II. Therapeutic Measures. Journal of
Endodontics 2004b; 11(12): 559-67.
Shariar S, Mokhtari H, Rahimi S, Yavari HR, Narimani S, Abdolrahimi M, Nezafati S.
Effect of Premedication with Ibuprofen and Dexamethasone on Success Rate of
Inferior Alveolar Nerve Block for Teeth with Asymptomatic Irreversible Pulpitis: A
Randomized Clinical Trial. Journal of Endodontics 2012; 39(2): 160-162.
Siqueira J. F, Barnett F. Interappointment Pain: Mechanisms, Diagnosis, and Treatment.
Endodontic Topics 2004; 7(1): 93-109.
Sohn W, Ismail W. Regular Dental Visits and Dental Anxiety in an Adult Dentate
Population. The Journal of the American Dental Association 2005; 136(1): 58-66.
Su Y, Wang C, Ye L. Healing Rate and Post-obturation Pain of Single- versus Multiplevisit Endodontic Treatment for Infected Root Canals: A Systematic Review.
Journal of Endodontics 2011; 37(2): 125-32.
Trowbridge H. Review of Dental Pain—histology and Physiology. Journal of
Endodontics 196; 12(10): 445-52.
Tsesis I, Faivishevsky V, Fuss Z, Zukerman O. Flare-ups after Endodontic Treatment: A
Meta-analysis of Literature. Journal of Endodontics 2008; 34(10): 1177-181.
Tuncer L, Alacam T, Oral B. Substance P Expression Is Elevated in Inflamed Human
Periradicular Tissue. Journal of Endodontics 2004; 30(5): 329-32.
Wayman B, Smith J, Cunningham C, Patten J, Hutchins M. Distribution of Injected
Dexamethasone from the Buccal Vestibule of the Rat Mandible. Journal of
Endodontics 1994; 20(11): 527-30.
Wong M, Lytle WR. A Comparison of Anxiety Levels Associated with Root Canal
Therapy and Oral Surgery Treatment. Journal of Endodontics 1991; 17(9): 461-65.

38!
Yingchun D, Weidong L, Wu W. Increased Expression of EphA7 in Inflamed Human
Dental Pulp. Journal of Endodontics 2013; 39(2): 223-27.
Lorne Y. The Use of Anesthetics, Steroids, Non-Steroidals, and Central-Acting
Analgesics in the Management of Ocular Pain. College of Optometry, Pacific
University. .
<http://www.pacificu.edu/optometry/ce/courses/22746/ocularpainpg1.cfm

